Clinical Perspectives on the Use of Different Peripheral Intravenous Catheters with the Implementation of Volume-based Procurement in China

Jian Ming; Hsing Jung Li; Yu Wang; Yunfan Ge; Jun Liu; Shanlian Hu

doi:doi:10.11648/j.sjph.20210902.13

| Peer-Reviewed

Clinical Perspectives on the Use of Different Peripheral Intravenous Catheters with the Implementation of Volume-based Procurement in China

Jian Ming, Hsing Jung Li, Yu Wang, Yunfan Ge, Jun Liu, Shanlian Hu

Published in Science Journal of Public Health (Volume 9, Issue 2)

Received: 27 February 2021 Accepted: 12 March 2021 Published: 26 March 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

China introduced a “volume-based procurement (VoBP)” policy for medical products to contain healthcare costs and improve patient access to cost-effective products recently. The VoBP of peripheral intravenous catheters (PIVCs) was piloted in Jiangsu, Shandong and Jiangxi provinces in late 2019. The bidding of PIVCs mainly focused on their prices, while the evaluation standard on clinical performance of PIVCs was less emphasized. In this study, we aim to understand the clinical impacts associated with the utilization of different PIVCs influenced by the implementation of VoBP policy in China. Semi-structured interviews were conducted with nurses in Nanjing and Linyi, the pilot cities implementing VoBP. A total of 27 nurses who used a leading multinational corporation’s (MNC’s) PIVCs before VoBP and changed to China local brands’ PIVCs after VoBP were included as informants. In the first 15 interviews, all domains (PIVC placement, complications, product issues, and training) and corresponding concepts listed in conceptual framework were mentioned, indicating that sample size was sufficient. After the change from the MNC’s PIVCs to local brands, PIVCs used per patient increased from 2.0 to 3.5 and the average indwelling time decreased from 3.7 days to 2.1 days. Compared with the MNC’s PIVCs, those from local brands were associated with a 0.9-minute increase in PIVC insertion time and a 9% relative decrease in first stick success rate. Furthermore, increased complication rate, quality issues and hard catheter materials, and reduced product training after PIVC change were also mentioned by nurses. This study discloses that PIVC product change following the implementation of VoBP may result in unexpected issues. Therefore, establishing quality evaluation criteria and strengthening product monitoring mechanism are recommended for VoBP policy optimization on medical consumables.

Published in	Science Journal of Public Health (Volume 9, Issue 2)
DOI	10.11648/j.sjph.20210902.13
Page(s)	49-56
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

Peripheral Intravenous Catheters, Volume-Based Procurement, Clinical Performance, Qualitative Research, China

References

[1]	Alexandrou E, Ray-Barruel G, Carr PJ, et al. Use of Short Peripheral Intravenous Catheters: Characteristics, Management, and Outcomes Worldwide. J Hosp Med. 2018; 13 (5).
[2]	Wei T, Li XY, Yue ZP, et al. Catheter dwell time and risk of catheter failure in adult patients with peripheral venous catheters. J Clin Nurs. 2019; 28 (23-24): 4488-95.
[3]	The Royal Children’s Hospital Melbourne, Clinical Guidelines: Peripheral intravenous (IV) device management. https://www.rch.org.au/rchcpg/hospital_clinical_guideline_index/Peripheral_Intravenous_IV_Device_Management/. Accessed May 26, 2020.
[4]	Sabri A, Szalas J, Holmes KS, et al. Failed attempts and improvement strategies in peripheral intravenous catheterization. Biomed Mater Eng. 2013; 23 (1-2): 93-108.
[5]	Sun H, Wang L, Guan X, et al. A survey of the status of infusion therapy in tertiary hospitals in China. Chinese Journal of Nursing. 2014; 49 (10): 1232-7.
[6]	Burton, Patrick. “4+7: China's New Volume-Based Purchasing Policy.” Pharma Boardroom, pharmaboardroom.com/articles/4-plus-7-chinas-new-volume-based-purchasing-policy/.
[7]	Yue, Xiao. “4+7” Drug Procurement Reform in China. China National Health Development Research Center, 2019.
[8]	The State Council of the People's Republic of China. Reform plan for managing high-value medical consumables. (2019) http://www.gov.cn/zhengce/content/2019-07/31/content_5417518.htm. Accessed May 26, 2020.
[9]	UNAIDS, Global HIV & AIDS statistics — 2020 fact sheet. https://www.unaids.org/en/resources/fact-sheet. Accessed Nov 1st 2020.
[10]	Portal, M. R. "Peripheral intravenous (IV) device management." R Child.
[11]	Tang M, He J, Chen M, et al. "4+7" city drug volume-based purchasing and using pilot program in China and its impact. Drug Discov Ther. 2019; 13 (6): 365-9.
[12]	Abolfotouh MA, Salam M, Bani-Mustafa A, et al. Prospective study of incidence and predictors of peripheral intravenous catheter-induced complications. Ther Clin Risk Manag. 2014; 10: 993-1001.
[13]	Gao ZL, Guo L, Li LZ, Comparison on the clinical outcome and cost-effectivemenss analysis of perirpheral intravenous catheter vs wing needle set in infusion therapy. China Journal of Pharmaceutical Economics. 2018 (02).
[14]	Cai Y, Zhu M, Sun W, et al. Study on the cost attributable to central venous catheter-related bloodstream infection and its influencing factors in a tertiary hospital in China. Health and quality of life outcomes. 2018; 16 (1): 1-6.
[15]	Kaur P, Rickard C, Domer GS, et al. Dangers of Peripheral Intravenous Catheterization: The Forgotten Tourniquet and Other Patient Safety Considerations. Vignettes in Patient Safety-Volume 4: IntechOpen; 2019.
[16]	Palinkas L A, Horwitz S M, Green C A, et al. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research [J]. Administration and policy in mental health and mental health services research, 2015, 42 (5): 533-544.
[17]	Li ML. Observation on the effect of bedside ward round on improving nursing ability. Contemporary Nurse: Specialist Edition, 2017 (8): p. 168-170.
[18]	Nelson J. Using conceptual depth criteria: addressing the challenge of reaching saturation in qualitative research. Qualitative research. 2017; 17 (5): 554-70.
[19]	Walker JL. The use of saturation in qualitative research. Can J Cardiovasc Nurs. 2012; 22 (2): 37-46.
[20]	Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field methods. 2006; 18 (1): 59-82.
[21]	Bowen GA. Naturalistic inquiry and the saturation concept: a research note. Qualitative research. 2008; 8 (1): 137-52.
[22]	Kerr C, Nixon A, Wild D. Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research. Expert review of pharmacoeconomics & outcomes research. 2010; 10 (3): 269-81.
[23]	Turner-Bowker DM, Lamoureux RE, Stokes J, et al. Informing a priori sample size estimation in qualitative concept elicitation interview studies for clinical outcome assessment instrument development. Value in Health. 2018; 21 (7): 839-42.
[24]	Nagpal K, Arora S, Vats A, et al. Failures in communication and information transfer across the surgical care pathway: interview study. BMJ Qual Saf. 2012; 21 (10): 843-9.
[25]	Cutcliffe JR. Methodological issues in grounded theory. Journal of advanced nursing. 2000; 31 (6): 1476-84.
[26]	Vinograd AM, Zorc JJ, Dean AJ, et al. First-attempt success, longevity, and complication rates of ultrasound-guided peripheral intravenous catheters in children. Pediatric emergency care. 2018; 34 (6): 376-80.
[27]	Yuan H, Chen LF, Chen YJ, et al. Effect comparison of three kinds of venous indwelling needles in adult inpatients. Journal of Nursing (China). 25.8 (2018): 51-54.
[28]	Legemaat M, Carr PJ, van Rens RM, et al. Peripheral intravenous cannulation: complication rates in the neonatal population: a multicenter observational study. The journal of vascular access. 2016; 17 (4): 360-5.
[29]	China National Health and Family Planning Commission. Nursing practice standards of intravenous therapy. 2014.
[30]	Jones RK. Short Peripheral Catheter Quality and Economics: The Intravenous Quotient. Journal of Infusion Nursing. 2018; 41 (6): 365-71.
[31]	Chen J, Yu SN, Wang, CL, et al. Clinical application of 3 types of venous indwelling needles. Journal of Guangdong Medical University. 01: 106-108. (2019).
[32]	Jacquot C, Fauvage B, Bru J, et al., editors. Effect of type of material on thrombophlebitis risk with peripheral venous catheters. ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION; 1989: EDITIONS SCIENTIFIQUES ELSEVIER 141 RUE JAVEL, 75747 PARIS CEDEX 15, FRANCE.
[33]	Karadag A, Görgülü S. Effect of two different short peripheral catheter materials on phlebitis development. Journal of Infusion Nursing. 2000; 23 (3): 158-66.
[34]	Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters: a randomized controlled trial. Annals of internal medicine. 1991; 114 (10): 845-54.
[35]	Yang CR, Huang XL, Chen MY, et al. Training of intravenous catheter system to junior nurses based on clinical nursing ability. Modern Clinical Nursing. 08: 59-64 (2018).
[36]	Keleekai NL, Schuster CA, Murray CL, et al. Improving nurses' peripheral intravenous catheter insertion knowledge, confidence, and skills using a simulation-based blended learning program: a randomized trial. Simulation in Healthcare. 2016; 11 (6): 376.
[37]	Armenteros-Yeguas V, Gárate-Echenique L, Tomás-López MA, et al. Prevalence of difficult venous access and associated risk factors in highly complex hospitalised patients. Journal of clinical nursing. 2017; 26 (23-24): 4267-75.
[38]	Doniger SJ, Ishimine P, Fox JC, et al. Randomized controlled trial of ultrasound-guided peripheral intravenous catheter placement versus traditional techniques in difficult-access pediatric patients. Pediatric emergency care. 2009; 25 (3): 154-9.
[39]	Naik VM, Mantha SSP, Rayani BK. Vascular access in children. Indian J Anaesth. 2019; 63 (9): 737-45.
[40]	Hu SL. Analysis on economics theoretical basis and impact in drug bulk purchasing with quantity. Soft Science of Health 01: 3-5 (2019).
[41]	Wei T, Tan P, Chen YY, et al. Survey of the use of peripheral venous catheters in adult patient. Journal of Nursing Science. 17 (2018): 4.
[42]	Zhang Y, Chen L. Analysis on the Application status and existing problems of intravenous indwelling needle in our hospital. Journal of Disease Monitor and Control. 7: 32 (2014).
[43]	Huang P, Liu LP, Wang L. Analysis of Current Status and Influencing Factors of Venous Indwelling Needles in Hospitals of Grade two and Above in Chongqing. Journal of Qilu Nursing, 23.14 (2017): 3-5.

Cite This Article

Plain Text BibTeX RIS

APA Style

Jian Ming, Hsing Jung Li, Yu Wang, Yunfan Ge, Jun Liu, et al. (2021). Clinical Perspectives on the Use of Different Peripheral Intravenous Catheters with the Implementation of Volume-based Procurement in China. Science Journal of Public Health, 9(2), 49-56. https://doi.org/10.11648/j.sjph.20210902.13

Copy | Download

ACS Style

Jian Ming; Hsing Jung Li; Yu Wang; Yunfan Ge; Jun Liu, et al. Clinical Perspectives on the Use of Different Peripheral Intravenous Catheters with the Implementation of Volume-based Procurement in China. Sci. J. Public Health 2021, 9(2), 49-56. doi: 10.11648/j.sjph.20210902.13

Copy | Download

AMA Style

Jian Ming, Hsing Jung Li, Yu Wang, Yunfan Ge, Jun Liu, et al. Clinical Perspectives on the Use of Different Peripheral Intravenous Catheters with the Implementation of Volume-based Procurement in China. Sci J Public Health. 2021;9(2):49-56. doi: 10.11648/j.sjph.20210902.13

Copy | Download

@article{10.11648/j.sjph.20210902.13,
  author = {Jian Ming and Hsing Jung Li and Yu Wang and Yunfan Ge and Jun Liu and Shanlian Hu},
  title = {Clinical Perspectives on the Use of Different Peripheral Intravenous Catheters with the Implementation of Volume-based Procurement in China},
  journal = {Science Journal of Public Health},
  volume = {9},
  number = {2},
  pages = {49-56},
  doi = {10.11648/j.sjph.20210902.13},
  url = {https://doi.org/10.11648/j.sjph.20210902.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjph.20210902.13},
  abstract = {China introduced a “volume-based procurement (VoBP)” policy for medical products to contain healthcare costs and improve patient access to cost-effective products recently. The VoBP of peripheral intravenous catheters (PIVCs) was piloted in Jiangsu, Shandong and Jiangxi provinces in late 2019. The bidding of PIVCs mainly focused on their prices, while the evaluation standard on clinical performance of PIVCs was less emphasized. In this study, we aim to understand the clinical impacts associated with the utilization of different PIVCs influenced by the implementation of VoBP policy in China. Semi-structured interviews were conducted with nurses in Nanjing and Linyi, the pilot cities implementing VoBP. A total of 27 nurses who used a leading multinational corporation’s (MNC’s) PIVCs before VoBP and changed to China local brands’ PIVCs after VoBP were included as informants. In the first 15 interviews, all domains (PIVC placement, complications, product issues, and training) and corresponding concepts listed in conceptual framework were mentioned, indicating that sample size was sufficient. After the change from the MNC’s PIVCs to local brands, PIVCs used per patient increased from 2.0 to 3.5 and the average indwelling time decreased from 3.7 days to 2.1 days. Compared with the MNC’s PIVCs, those from local brands were associated with a 0.9-minute increase in PIVC insertion time and a 9% relative decrease in first stick success rate. Furthermore, increased complication rate, quality issues and hard catheter materials, and reduced product training after PIVC change were also mentioned by nurses. This study discloses that PIVC product change following the implementation of VoBP may result in unexpected issues. Therefore, establishing quality evaluation criteria and strengthening product monitoring mechanism are recommended for VoBP policy optimization on medical consumables.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Clinical Perspectives on the Use of Different Peripheral Intravenous Catheters with the Implementation of Volume-based Procurement in China
AU  - Jian Ming
AU  - Hsing Jung Li
AU  - Yu Wang
AU  - Yunfan Ge
AU  - Jun Liu
AU  - Shanlian Hu
Y1  - 2021/03/26
PY  - 2021
N1  - https://doi.org/10.11648/j.sjph.20210902.13
DO  - 10.11648/j.sjph.20210902.13
T2  - Science Journal of Public Health
JF  - Science Journal of Public Health
JO  - Science Journal of Public Health
SP  - 49
EP  - 56
PB  - Science Publishing Group
SN  - 2328-7950
UR  - https://doi.org/10.11648/j.sjph.20210902.13
AB  - China introduced a “volume-based procurement (VoBP)” policy for medical products to contain healthcare costs and improve patient access to cost-effective products recently. The VoBP of peripheral intravenous catheters (PIVCs) was piloted in Jiangsu, Shandong and Jiangxi provinces in late 2019. The bidding of PIVCs mainly focused on their prices, while the evaluation standard on clinical performance of PIVCs was less emphasized. In this study, we aim to understand the clinical impacts associated with the utilization of different PIVCs influenced by the implementation of VoBP policy in China. Semi-structured interviews were conducted with nurses in Nanjing and Linyi, the pilot cities implementing VoBP. A total of 27 nurses who used a leading multinational corporation’s (MNC’s) PIVCs before VoBP and changed to China local brands’ PIVCs after VoBP were included as informants. In the first 15 interviews, all domains (PIVC placement, complications, product issues, and training) and corresponding concepts listed in conceptual framework were mentioned, indicating that sample size was sufficient. After the change from the MNC’s PIVCs to local brands, PIVCs used per patient increased from 2.0 to 3.5 and the average indwelling time decreased from 3.7 days to 2.1 days. Compared with the MNC’s PIVCs, those from local brands were associated with a 0.9-minute increase in PIVC insertion time and a 9% relative decrease in first stick success rate. Furthermore, increased complication rate, quality issues and hard catheter materials, and reduced product training after PIVC change were also mentioned by nurses. This study discloses that PIVC product change following the implementation of VoBP may result in unexpected issues. Therefore, establishing quality evaluation criteria and strengthening product monitoring mechanism are recommended for VoBP policy optimization on medical consumables.
VL  - 9
IS  - 2
ER  -

Copy | Download

Author Information

Jian Ming

Real World Solutions, IQVIA China, Shanghai, China
Hsing Jung Li

Real World Solutions, IQVIA China, Shanghai, China
Yu Wang

Real World Solutions, IQVIA China, Shanghai, China
Yunfan Ge

Primary Intelligence, IQVIA China, Shanghai, China
Jun Liu

Real World Solutions, IQVIA China, Shanghai, China
Shanlian Hu

School of Public Health, Fudan University, Shanghai, China

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Jian Ming, Hsing Jung Li, Yu Wang, Yunfan Ge, Jun Liu, et al. (2021). Clinical Perspectives on the Use of Different Peripheral Intravenous Catheters with the Implementation of Volume-based Procurement in China. Science Journal of Public Health, 9(2), 49-56. https://doi.org/10.11648/j.sjph.20210902.13

Copy | Download

ACS Style

Jian Ming; Hsing Jung Li; Yu Wang; Yunfan Ge; Jun Liu, et al. Clinical Perspectives on the Use of Different Peripheral Intravenous Catheters with the Implementation of Volume-based Procurement in China. Sci. J. Public Health 2021, 9(2), 49-56. doi: 10.11648/j.sjph.20210902.13

Copy | Download

AMA Style

Jian Ming, Hsing Jung Li, Yu Wang, Yunfan Ge, Jun Liu, et al. Clinical Perspectives on the Use of Different Peripheral Intravenous Catheters with the Implementation of Volume-based Procurement in China. Sci J Public Health. 2021;9(2):49-56. doi: 10.11648/j.sjph.20210902.13

Copy | Download

@article{10.11648/j.sjph.20210902.13,
  author = {Jian Ming and Hsing Jung Li and Yu Wang and Yunfan Ge and Jun Liu and Shanlian Hu},
  title = {Clinical Perspectives on the Use of Different Peripheral Intravenous Catheters with the Implementation of Volume-based Procurement in China},
  journal = {Science Journal of Public Health},
  volume = {9},
  number = {2},
  pages = {49-56},
  doi = {10.11648/j.sjph.20210902.13},
  url = {https://doi.org/10.11648/j.sjph.20210902.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjph.20210902.13},
  abstract = {China introduced a “volume-based procurement (VoBP)” policy for medical products to contain healthcare costs and improve patient access to cost-effective products recently. The VoBP of peripheral intravenous catheters (PIVCs) was piloted in Jiangsu, Shandong and Jiangxi provinces in late 2019. The bidding of PIVCs mainly focused on their prices, while the evaluation standard on clinical performance of PIVCs was less emphasized. In this study, we aim to understand the clinical impacts associated with the utilization of different PIVCs influenced by the implementation of VoBP policy in China. Semi-structured interviews were conducted with nurses in Nanjing and Linyi, the pilot cities implementing VoBP. A total of 27 nurses who used a leading multinational corporation’s (MNC’s) PIVCs before VoBP and changed to China local brands’ PIVCs after VoBP were included as informants. In the first 15 interviews, all domains (PIVC placement, complications, product issues, and training) and corresponding concepts listed in conceptual framework were mentioned, indicating that sample size was sufficient. After the change from the MNC’s PIVCs to local brands, PIVCs used per patient increased from 2.0 to 3.5 and the average indwelling time decreased from 3.7 days to 2.1 days. Compared with the MNC’s PIVCs, those from local brands were associated with a 0.9-minute increase in PIVC insertion time and a 9% relative decrease in first stick success rate. Furthermore, increased complication rate, quality issues and hard catheter materials, and reduced product training after PIVC change were also mentioned by nurses. This study discloses that PIVC product change following the implementation of VoBP may result in unexpected issues. Therefore, establishing quality evaluation criteria and strengthening product monitoring mechanism are recommended for VoBP policy optimization on medical consumables.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Clinical Perspectives on the Use of Different Peripheral Intravenous Catheters with the Implementation of Volume-based Procurement in China
AU  - Jian Ming
AU  - Hsing Jung Li
AU  - Yu Wang
AU  - Yunfan Ge
AU  - Jun Liu
AU  - Shanlian Hu
Y1  - 2021/03/26
PY  - 2021
N1  - https://doi.org/10.11648/j.sjph.20210902.13
DO  - 10.11648/j.sjph.20210902.13
T2  - Science Journal of Public Health
JF  - Science Journal of Public Health
JO  - Science Journal of Public Health
SP  - 49
EP  - 56
PB  - Science Publishing Group
SN  - 2328-7950
UR  - https://doi.org/10.11648/j.sjph.20210902.13
AB  - China introduced a “volume-based procurement (VoBP)” policy for medical products to contain healthcare costs and improve patient access to cost-effective products recently. The VoBP of peripheral intravenous catheters (PIVCs) was piloted in Jiangsu, Shandong and Jiangxi provinces in late 2019. The bidding of PIVCs mainly focused on their prices, while the evaluation standard on clinical performance of PIVCs was less emphasized. In this study, we aim to understand the clinical impacts associated with the utilization of different PIVCs influenced by the implementation of VoBP policy in China. Semi-structured interviews were conducted with nurses in Nanjing and Linyi, the pilot cities implementing VoBP. A total of 27 nurses who used a leading multinational corporation’s (MNC’s) PIVCs before VoBP and changed to China local brands’ PIVCs after VoBP were included as informants. In the first 15 interviews, all domains (PIVC placement, complications, product issues, and training) and corresponding concepts listed in conceptual framework were mentioned, indicating that sample size was sufficient. After the change from the MNC’s PIVCs to local brands, PIVCs used per patient increased from 2.0 to 3.5 and the average indwelling time decreased from 3.7 days to 2.1 days. Compared with the MNC’s PIVCs, those from local brands were associated with a 0.9-minute increase in PIVC insertion time and a 9% relative decrease in first stick success rate. Furthermore, increased complication rate, quality issues and hard catheter materials, and reduced product training after PIVC change were also mentioned by nurses. This study discloses that PIVC product change following the implementation of VoBP may result in unexpected issues. Therefore, establishing quality evaluation criteria and strengthening product monitoring mechanism are recommended for VoBP policy optimization on medical consumables.
VL  - 9
IS  - 2
ER  -

Copy | Download